Lopinavir-Ritonavir No Benefit in Adults With Severe COVID-19

FRIDAY, March 20, 2020 -- Lopinavir-ritonavir treatment offers no significant benefit over standard care for hospitalized adult patients with severe coronavirus 2019 (COVID-19) infection, according to a study published online March 18 in the New...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news